(Q37148326)

18 August 2017

Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy (English)

1 reference

18 August 2017

0 references

0 references

congenital heart disease

1 reference

4

Jennifer L St Sauver

1 reference

18 August 2017

Christina L Wichman

1

1 reference

18 August 2017

Katherine M Moore

2

1 reference

18 August 2017

Tara R Lang

3

1 reference

18 August 2017

Robert H Heise

5

1 reference

18 August 2017

William J Watson

6

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

18 August 2017

1 reference

18 August 2017

84

1 reference

18 August 2017

1

1 reference

18 August 2017

23-27

1 reference

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664566

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664566

Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664566

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664566

Risks associated with selective serotonin reuptake inhibitors in pregnancy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664566

Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664566

Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664566

Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664566

Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664566

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664566

Congenital heart disease in the general population: changing prevalence and age distribution.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664566

Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664566

Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664566

Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664566

Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664566

Paroxetine in the first trimester and the prevalence of congenital malformations

3 September 2018

1 reference

12 December 2020

Birth outcomes in pregnant women taking fluoxetine

1 reference

12 December 2020

Selective serotonin reuptake inhibitors and adverse pregnancy outcomes

1 reference

12 December 2020

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage

1 reference

12 December 2020

Identifiers

DOI

10.4065/84.1.23

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19121250

1 reference